Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

People who oppose vaccination – the so-called “anti-vaxxers” – are often thought to be the reason for low vaccination rates. The truth is, anti-vaxxers don’t wholly explain low vaccination rates. The influence of the movement is often exaggerated and does not properly explain a complex situation.

Two main reasons point to why people who have anti-vaccine beliefs and attitudes are not the sole cause of low vaccination. 

Read the full article on The Conversation website, written by Samantha Vanderslott, Department of Paediatrics. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.

How do muscles make us strong? Find out at IF Oxford Science & Ideas Festival

If you've ever wondered about the role of the muscle, come and meet us at IF Oxford - the Oxford science and ideas Festival on Saturday 8th & 15th October, when our researchers will be challenging members of the public to play our "Muscle Switch" game and exploring why strength differs between us.

It’s not just Covid: the triple threat that could overwhelm the NHS this winter - Andrew Pollard

A severe flu outbreak or new coronavirus variant could prove catastrophic for a health service already on its knees

Study raises hope of pre-school type 1 diabetes screening programme

Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.